Compound 2305
Identifiers
- Canonical SMILES:
OC1(CCNCC1)c1ccc(Cl)cc1
- IUPAC name:
4-(4-chlorophenyl)piperidin-4-ol
- InChi:
InChI=1S/C11H14ClNO/c12-10-3-1-9(2-4-10)11(14)5-7-13-8-6-11/h1-4,13-14H,5-8H2
- InChiKey:
LZAYOZUFUAMFLD-UHFFFAOYSA-N
External links
![]() 38282 |
![]() CHEMBL3298755 |
WD5 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BAZ2-like PHD / H3 | 2.33 | prostate cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 211.08 g/mol | |||
HBA | 2 | |||
HBD | 2 | |||
HBA + HBD | 4 | |||
AlogP | 1.38 | |||
TPSA | 36.84 | |||
RB | 1 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acschembio.7b01093 | Fr5 | BAZ2A Q9UIF9 |
H31 P68431 |
Biochemical assay | NMR chemical-shift perturbation BAZ2A PHD | pKd (dissociation constant, -log10) | 2.33 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8088 | Halofantrine | DB01218 | |
0.7500 | Pridinol | DB13642 | |
0.7160 | Haloperidol | DB00502 | |
0.7160 | Loperamide | DB00836 | |
0.7042 | Pitolisant | DB11642 | |
0.6956 | Clofedanol | DB04837 | |
0.6923 | Clobutinol | DB09004 | |
0.6857 | Trihexyphenidyl | DB00376 | |
0.6857 | Cycrimine | DB00942 | |
0.6812 | Tridihexethyl | DB00505 | |
0.6744 | Penfluridol | DB13791 | |
0.6667 | Fenpropidin | DB12728 | |
0.6667 | Quifenadine | DB13713 | |
0.6620 | Procyclidine | DB00387 | |
0.6517 | Loperamide oxide | DB14661 |